13 years in life sciences. Now I read what AI writes about it.

I spent three years at Servier and ten at Pfizer, on the commercial side. I was a rep. I know how long it takes to get one sentence approved, and why nobody wants to touch it afterwards.

That’s what I bring to AI. When an answer for a Canadian patient cites an American page, I notice. When a rep asks what they’re allowed to do with Copilot, I know the question behind the question.

I’m also a rare disease patient. I was diagnosed with common variable immune deficiency (CVID) in 2019, and I actively advocate for people’s health using technology and AI.

Inpharmativ began by finding the specialists commercial teams were missing, and we still do. Then clients started asking something new: what is AI saying about us, and how do we use it ourselves? That’s now the work we lead with.

You’ll work with me directly.

Steve Walters

Founder, Inpharmativ Consulting Inc.

Steve Walters, founder of Inpharmativ, in a grey suit with his arms crossed

What we do.

Your team

AI Implementation

Training and agents for reps, MSLs and brand teams, built from how they really work, on the tools you’ve approved, inside your rules.

Read more

What AI tells people

AI Visibility

What ChatGPT, Google AI Overviews, Gemini, Copilot, Perplexity and Claude tell patients about your medicine, with every answer stored and every source shown.

Read more

The physicians

KOL and Data

KOL mapping, list validation and conference intelligence, with every name checked against its source.

Read more

Featured by Roche Canada, IG Living, Canadian Blood Services and Patient Voice. See the work

Speaking engagements include the Canadian Society for Transfusion Medicine Annual Scientific Conference, Roche Canada, Takeda and the Canadian Vascular Access Association. See the list

Bring one real question to the call.

Tell me what you’re working on. In 30 minutes we’ll work out whether I can help.